|
Quote |
Price | |
$17.63 |
|
Price change for today in $ | |
-0.70 |
|
Price change for today in % | |
-3.82 |
|
Open Price | |
$18.28 |
|
Previous Close | |
$18.33 |
|
Daily Range | |
$17.43 - $18.72 |
|
52-Week Range | |
$13.59 - $22.55 |
|
Volume | |
540,531 |
|
| |
 |
| |
Brokerage Analyst Recommendations
|
| 13 Brokerage Firms Covering AUXL |
| |
|
Strong Buy
7 |
Buy
1 |
Hold
3 |
Sell
0 |
Strong Sell
2 |
|
| Average Broker Recommendation (ABR):2.15 |
| |
|
| Description |
| Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease. |
| |
40 VALLEY STREAM PARKWAY
MALVERN, PA
19355, USA
Phone: 4843215900
Fax: 484-321-5999
Web: http://www.auxilium.com/
|
Industry:MED-DRUGS
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:03/31/12
Next EPS Date:08/06/12 |
|
|
